98733175 - UPONUREG

Information

  • Trademark
  • 98733175
  • Serial Number
    98733175
  • Filing Date
    September 04, 2024
    a year ago
  • Transaction Date
    July 22, 2025
    4 months ago
  • Status Date
    July 22, 2025
    4 months ago
  • Published for Opposition Date
    July 22, 2025
    4 months ago
  • Location Date
    July 02, 2025
    5 months ago
  • Status Code
    686
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    GUTTADAURO, JULIE
  • Attorney Docket Number
    00164242-US
    Attorney Name
    Marilyn. F. Kelly
    Law Office Assigned Location Code
    L60
  • Owners
Mark Drawing Code
4
Mark Identification
UPONUREG
Case File Statements
  • GS0051: Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressant preparations, pharmaceutical antibodies for medical use, and immunotherapy preparations for the treatment of cancer; cytokine inhibitory drugs for human use being pharmaceutical preparations for the treatment of cancer; anticoagulants for human use; Pharmaceutical preparations for human use that modulate the immune system for the treatment of immune-system related diseases and disorders; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy preparations for the treatment of cancer; Pharmaceutical and biological preparations for human use, namely, stem cells for medical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use; Pharmaceutical preparations for human use for the treatment of neuropsychiatric disorders; therapeutic radiopharmaceutical preparations for human use for the treatment of cancer and solid tumors; diagnostic radiopharmaceutical preparations for human use; diagnostic preparations for human use for medical purposes; radiopharmaceutical preparations for human use in the nature of imaging and detection agents for diagnosing and monitoring cancer; biological preparations for human use in the nature of radio-isotope markers for therapeutic or diagnostic use; Pharmaceutical preparations for human use for the treatment of cystic fibrosis.
Case File Event Statements
  • 9/4/2024 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 3/14/2025 - 9 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/17/2025 - 9 months ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/17/2025 - 9 months ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/17/2025 - 9 months ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/16/2025 - 5 months ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/16/2025 - 5 months ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/17/2025 - 5 months ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/17/2025 - 5 months ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/16/2025 - 4 months ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/22/2025 - 4 months ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/22/2025 - 4 months ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/16/2025 - 9 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK